Live Quote · NASDAQCOAGHealthcare· Biotechnology

Hemab Therapeutics Holdings, Inc. Common Stock

$39.29▼ 1.43%($-0.57)
MKT CAP $1.84BNEXT EARNINGS Feb 9, 2027
50%
Bullish
TickerSpark Score
54/100
▌ Mixed
67
Valuation
20
Profitability
20
Growth
84
Health
80
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a COAG research report →

Analyst Price Target
$54.50+38.7% vs. today

Range $36 – $70

Analyst RatingBuy
3 Buy0 Hold0 Sell

Price Chart

+17.24% · this period
$54.94$39.96$24.98May 01Aug 12Nov 19
52-Week Range50% of range
Low
$23.00
Current
$39.29
High
$55.42